Search clinical trials for: Hemoglobin Based Oxygen Carrier-201 (HBOC-201, Hemopure)

Total 9 results

Biopure Corporation

Completed

Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization

Acute Coronary Syndrome | Coronary Occlusion

Netherlands
Jonathan H. Waters
HbO2 Therapeutics LLC

Available

Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

Anemia Severe

United States
Johns Hopkins University

Available

Expanded Access Protocol Using HBOC-201

Anemia

United States
Englewood Hospital and Medical Center
HbO2 Therapeutics LLC

Enrolling by invitation

Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia

Anemia

United States
Biopure Corporation

Unknown

A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects

Wounds and Injuries

South Africa
Biopure Corporation

Completed

Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization

Myocardial Infarction | Angina Pectoris | Unstable Angina

Belgium, Germany, Netherlands
Mauricio Lynn

Available

HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option

Anemia

United States
Biopure Corporation

Terminated

Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia

Peripheral Vascular Disease

United Kingdom, South Africa
Biopure Corporation

Unknown

A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery

Coronary Artery Disease

Greece, South Africa, United Kingdom

Search clinical trials for: Hemoglobin Based Oxygen Carrier-201 (HBOC-201, Hemopure)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations